Data Portal @ linkeddatafragments.org

Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Alexion_Pharmaceuticals> ?p ?o. }

• Alexion_Pharmaceuticals abstract "Alexion Pharmaceuticals is the original developer and distributor of Soliris, a drug used in treating the rare disorders atypical hemolytic uremic syndrome (aHUS) and Paroxysmal nocturnal hemoglobinuria (PNH).The company is also involved in research regarding the immune system and how it can be stopped from attacking healthy tissue (done by inhibiting terminal complements).Soliris, the company's sole marketed drug, has been approved for use in the EU and Japan however its availability in other places like the USA and Canada is limited due to marketing restrictions and lack of ensured access (in Canada access to the drug is mostly through private clinics though groups like the Canadian Association of PNH Patients are lobbying to change that).In 2012 37% of sales originated in the US down from 43%, with 35% coming from Europe up from 34%. In 2011 50% of the increase in assets came from cash and cash equivalents, the value of which has since gone down since part of it was spent on acquiring Enobia. In the last quarter R&D spending was higher due to expansion of development programs while net sales of Soliris increased 45% to $227.6 million on account of new international patients with paroxysmal nocturnal hemoglobinuria. By September 2013 quarterly sales of Soliris topped $400 million.".
• Alexion_Pharmaceuticals assets "2.61356".
• Alexion_Pharmaceuticals equity "1.97085".
• Alexion_Pharmaceuticals foundingYear "1992".
• Alexion_Pharmaceuticals industry Pharmaceutical_industry.
• Alexion_Pharmaceuticals keyPerson Chairman.
• Alexion_Pharmaceuticals keyPerson Chief_executive_officer.
• Alexion_Pharmaceuticals locationCity Cheshire,_Connecticut.
• Alexion_Pharmaceuticals locationCity Connecticut.
• Alexion_Pharmaceuticals locationCity United_States.
• Alexion_Pharmaceuticals netIncome "254.822".
• Alexion_Pharmaceuticals numberOfEmployees "1500".
• Alexion_Pharmaceuticals operatingIncome "404.338".
• Alexion_Pharmaceuticals product Eculizumab.
• Alexion_Pharmaceuticals revenue "1.134114E9".
• Alexion_Pharmaceuticals type Public_company.
• Alexion_Pharmaceuticals wikiPageExternalLink www.alxn.com.
• Alexion_Pharmaceuticals wikiPageID "31443674".
• Alexion_Pharmaceuticals wikiPageRevisionID "603838431".
• Alexion_Pharmaceuticals assets "US$ 2.61356 bil (87%)".
• Alexion_Pharmaceuticals equity "US$ 1.97085 bil (74%)".
• Alexion_Pharmaceuticals foundation "1992".
• Alexion_Pharmaceuticals hasPhotoCollection Alexion_Pharmaceuticals.
• Alexion_Pharmaceuticals homepage www.alxn.com.
• Alexion_Pharmaceuticals industry Pharmaceutical_industry.
• Alexion_Pharmaceuticals keyPeople "Leonard Bell".
• Alexion_Pharmaceuticals keyPeople "Max E. Link".
• Alexion_Pharmaceuticals locationCity Cheshire,_Connecticut.
• Alexion_Pharmaceuticals locationCity Connecticut.
• Alexion_Pharmaceuticals locationCity United_States.
• Alexion_Pharmaceuticals logo "275".
• Alexion_Pharmaceuticals name "Alexion Pharmaceuticals".
• Alexion_Pharmaceuticals netIncome "US$ 254.822 mil (45%)".
• Alexion_Pharmaceuticals numEmployees "1500".
• Alexion_Pharmaceuticals operatingIncome "US$ 404.338 mil (75%)".
• Alexion_Pharmaceuticals products Eculizumab.
• Alexion_Pharmaceuticals revenue "US$ 1134.114 million 45%".
• Alexion_Pharmaceuticals tradedAs S&P_500.
• Alexion_Pharmaceuticals type Public_company.
• Alexion_Pharmaceuticals subject Category:Companies_based_in_Connecticut.
• Alexion_Pharmaceuticals subject Category:Companies_in_the_NASDAQ-100_Index.
• Alexion_Pharmaceuticals subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
• Alexion_Pharmaceuticals subject Category:Companies_listed_on_NASDAQ.
• Alexion_Pharmaceuticals subject Category:Pharmaceutical_companies_of_the_United_States.
• Alexion_Pharmaceuticals type Abstraction100002137.
• Alexion_Pharmaceuticals type CompaniesBasedInConnecticut.
• Alexion_Pharmaceuticals type CompaniesInTheNASDAQ-100Index.
• Alexion_Pharmaceuticals type CompaniesListedOnNASDAQ.
• Alexion_Pharmaceuticals type Company108058098.
• Alexion_Pharmaceuticals type DrugCompany108002578.
• Alexion_Pharmaceuticals type Group100031264.
• Alexion_Pharmaceuticals type Institution108053576.
• Alexion_Pharmaceuticals type Organization108008335.
• Alexion_Pharmaceuticals type PharmaceuticalCompanies.
• Alexion_Pharmaceuticals type SocialGroup107950920.
• Alexion_Pharmaceuticals type YagoLegalActor.
• Alexion_Pharmaceuticals type YagoLegalActorGeo.
• Alexion_Pharmaceuticals type YagoPermanentlyLocatedEntity.
• Alexion_Pharmaceuticals type Agent.
• Alexion_Pharmaceuticals type Company.
• Alexion_Pharmaceuticals type Organisation.
• Alexion_Pharmaceuticals type Organization.
• Alexion_Pharmaceuticals type Agent.
• Alexion_Pharmaceuticals type SocialPerson.
• Alexion_Pharmaceuticals type Thing.
• Alexion_Pharmaceuticals comment "Alexion Pharmaceuticals is the original developer and distributor of Soliris, a drug used in treating the rare disorders atypical hemolytic uremic syndrome (aHUS) and Paroxysmal nocturnal hemoglobinuria (PNH).The company is also involved in research regarding the immune system and how it can be stopped from attacking healthy tissue (done by inhibiting terminal complements).Soliris, the company's sole marketed drug, has been approved for use in the EU and Japan however its availability in other places like the USA and Canada is limited due to marketing restrictions and lack of ensured access (in Canada access to the drug is mostly through private clinics though groups like the Canadian Association of PNH Patients are lobbying to change that).In 2012 37% of sales originated in the US down from 43%, with 35% coming from Europe up from 34%. ".
• Alexion_Pharmaceuticals label "Alexion Pharmaceuticals".
• Alexion_Pharmaceuticals label "Alexion Pharmaceuticals".
• Alexion_Pharmaceuticals label "Alexion Pharmaceuticals".
• Alexion_Pharmaceuticals label "Alexion Pharmaceuticals".
• Alexion_Pharmaceuticals sameAs Alexion_Pharmaceuticals.
• Alexion_Pharmaceuticals sameAs Alexion_Pharmaceuticals.
• Alexion_Pharmaceuticals sameAs Alexion_Pharmaceuticals.
• Alexion_Pharmaceuticals sameAs m.02_7bwl.
• Alexion_Pharmaceuticals sameAs Q204727.
• Alexion_Pharmaceuticals sameAs Q204727.
• Alexion_Pharmaceuticals sameAs Alexion_Pharmaceuticals.
• Alexion_Pharmaceuticals wasDerivedFrom Alexion_Pharmaceuticals?oldid=603838431.
• Alexion_Pharmaceuticals homepage www.alxn.com.
• Alexion_Pharmaceuticals isPrimaryTopicOf Alexion_Pharmaceuticals.
• Alexion_Pharmaceuticals name "Alexion Pharmaceuticals".